Urinary Bladder Neoplasm Clinical Trial
Official title:
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
This study investigates if reduced muscle mass and muscle function predispose to poor completion of oncological treatment in patients with bladder cancer (including cancer of the renal pelvis, ureter and urethra) and if muscle mass and muscle function change during oncological treatment in these patients. It also evaluates biomarkers for sarcopenia.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05429710 -
SOX2 & PDL1 Expression on Urinary Bladder Carcinoma
|
||
| Not yet recruiting |
NCT05097105 -
Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses
|
||
| Completed |
NCT02977143 -
Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery
|
N/A | |
| Completed |
NCT02966535 -
The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial
|
N/A | |
| Completed |
NCT05946369 -
Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer
|
||
| Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06238479 -
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Completed |
NCT02311101 -
Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
|
Phase 1 | |
| Recruiting |
NCT04811846 -
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
|
N/A | |
| Not yet recruiting |
NCT06465069 -
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04576286 -
Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder
|
Phase 3 | |
| Completed |
NCT02857634 -
Confocal Microscopy Dual Band in the Management of Bladder Cancer
|
||
| Recruiting |
NCT04561362 -
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04442724 -
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
|
N/A | |
| Recruiting |
NCT04029948 -
Laser vs. Electorsurgical Enbloc Resection of Bladder Tumours
|
N/A | |
| Terminated |
NCT03389438 -
Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma
|
Phase 2 | |
| Terminated |
NCT02952989 -
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06237920 -
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
|
Phase 2 | |
| Completed |
NCT03785925 -
A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer
|
Phase 2 | |
| Completed |
NCT03636256 -
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
|
Phase 1/Phase 2 |